{
    "title": "112_hr396",
    "content": "The Act may be cited as the \"TBI Treatment Act\" and includes a pilot program for the payment of treatment for members of the Armed Forces and veterans with traumatic brain injury and post-traumatic stress disorder. The \"TBI Treatment Act\" establishes a pilot program for payment of treatments for traumatic brain injury and post-traumatic stress disorder for members of the Armed Forces and veterans. The program requires the Secretaries of Defense and Veterans Affairs to establish a payment process for treatments provided in non-military or VA health care facilities, with payments made directly to the facility. Approval for payment is subject to conditions including the use of FDA-approved drugs or devices. The TBI Treatment Act establishes a pilot program for payment of treatments for traumatic brain injury and post-traumatic stress disorder for members of the Armed Forces and veterans. The treatment must be approved by an institutional review board and used by the health care provider. The patient must show improvement through various assessments, and the treatment must be FDA-approved. The TBI Treatment Act pilot program allows for payment of treatments for traumatic brain injury and post-traumatic stress disorder for members of the Armed Forces and veterans. Patients must receive treatment voluntarily, with no restrictions on reimbursement for lawful healthcare providers. Payment for treatment must be made within 30 days by the Secretaries of Defense and Veterans Affairs. The TBI Treatment Act pilot program allows payment for treatments for traumatic brain injury and post-traumatic stress disorder for members of the Armed Forces and veterans. The Secretaries of Defense and Veterans Affairs must ensure that documentation for treatment is not burdensome and make payments within 30 days using specific authorities. The TBI Treatment Act pilot program allows payment for treatments for traumatic brain injury and post-traumatic stress disorder for members of the Armed Forces and veterans. Payments are made at Medicare and Medicaid reimbursement rates or fair market rates determined by the Secretaries of Defense and Health and Human Services or Veterans Affairs. Data collection and availability are jointly maintained by the Secretaries of Defense and Veterans Affairs. The database containing patient case data for treatments under the TBI Treatment Act is confidential and accessible only to third-party payers, congressional committees, relevant government agencies, and institutional review boards. Patient enrollment in institutional review board studies is also required. The TBI Treatment Act ensures confidentiality of patient case data for treatments, accessible to authorized parties. Institutional review board studies require patient enrollment. Secretaries of Defense and Veterans Affairs must list civilian studies receiving payments. Military members may be assigned temporary duty for treatment assistance. The military department can assign Armed Forces members to temporary duty for treatment of traumatic brain injury or post-traumatic stress disorder at a location beyond their permanent duty station. Per diem may be paid to members away from their permanent station. Gift rule waivers may apply. The Act exempts assistance for Armed Forces members with service-connected injuries from ethics rules. Retaliation is prohibited against those receiving treatment in a civilian study. University and accredited institutional review boards are treated like Government boards. Memoranda of Understanding are established by the Secretary of Defense. The Secretary of Defense and the Secretary of Veterans Affairs aim to quickly establish agreements with civilian institutional review boards for Armed Forces members and veterans to receive approved treatment from civilian health care practitioners. Outreach is required for notifying veterans and members of the Armed Forces about the treatment opportunities under this Act. The Secretary of Defense and the Secretary of Veterans Affairs must inform service members with service-connected injuries of treatment opportunities under this Act. A joint report to Congress is required annually, detailing the number of individuals receiving payments, their conditions, treatment success rates, and methods used by treatment entities. The Act requires entities receiving payment to disclose treatment methods and success rates. The Secretaries must recommend integrating these methods into Department of Defense and Veterans Affairs facilities. The Act's payment authority ends five years after enactment, with an annual appropriation of $10,000,000 for implementation."
}